Literature DB >> 9588530

An MRI and MRS study of Pelizaeus-Merzbacher disease.

A Nezu1, S Kimura, S Takeshita, H Osaka, K Kimura, K Inoue.   

Abstract

Earlier reports on T2-weighted magnetic resonance imaging (MRI) in the classical form of Pelizaeus-Merzbacher disease seemed to divide the patterns of the high-intensity lesions in the white matter into three subtypes: type I, diffusely hemispheric and corticospinal; type II, diffusely hemispheric without brainstem lesions; and type III, patchy in the hemispheres. The four boys presented in our study, between 10 and 17 years of age, with classical Pelizaeus-Merzbacher disease, who all had a duplicated proteolipid protein gene, invariably manifested type I despite their various clinical severities. Follow-up MRI after an interval of 5 years and proton magnetic resonance spectroscopy was performed in three of the patients. The white matter on the last MRI was unchanged in volume and the distribution of high-intense areas. Proton magnetic resonance spectroscopy revealed no abnormal peaks. These results were consistent with the lack of definite neurologic regression in the last 5 years and with the pathologic characteristics of well-preserved axons and the absence of sclerosis. Further study is required to precisely determine whether the patterns of MRI findings can be divided into subtypes corresponding to those of proteolipid protein gene abnormalities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588530     DOI: 10.1016/s0887-8994(97)00212-9

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

1.  MR-revealed myelination in the cerebral corticospinal tract as a marker for Pelizaeus-Merzbacher's disease with proteolipid protein gene duplication.

Authors:  J Takanashi; K Sugita; Y Tanabe; K Nagasawa; K Inoue; H Osaka; Y Kohno
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

2.  Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination.

Authors:  Nicole I Wolf; Maria Cundall; Paul Rutland; Elisabeth Rosser; Robert Surtees; Sarah Benton; Wui K Chong; Sue Malcolm; Friedrich Ebinger; Maria Bitner-Glindzicz; Karen J Woodward
Journal:  Neurogenetics       Date:  2006-09-13       Impact factor: 2.660

Review 3.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Authors:  Ken Inoue
Journal:  Neurogenetics       Date:  2004-12-31       Impact factor: 2.660

4.  Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease.

Authors:  Francesca Pizzini; Ali S Fatemi; Peter B Barker; Lidia M Nagae-Poetscher; Alena Horská; Andrew W Zimmerman; Hugo W Moser; Genila Bibat; Sakkubai Naidu
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

5.  Neuroradiologic correlates of clinical disability and progression in the X-linked leukodystrophy Pelizaeus-Merzbacher disease.

Authors:  Jeremy J Laukka; Jeffrey A Stanley; James Y Garbern; Angela Trepanier; Grace Hobson; Tori Lafleur; Alexander Gow; John Kamholz
Journal:  J Neurol Sci       Date:  2013-08-30       Impact factor: 3.181

6.  Pathology of the neurovascular unit in leukodystrophies.

Authors:  Parand Zarekiani; Marjolein Breur; Nicole I Wolf; Helga E de Vries; Marjo S van der Knaap; Marianna Bugiani
Journal:  Acta Neuropathol Commun       Date:  2021-06-03       Impact factor: 7.801

Review 7.  The neurovascular unit in leukodystrophies: towards solving the puzzle.

Authors:  Parand Zarekiani; Henrique Nogueira Pinto; Marianna Bugiani; Helga E de Vries; Elly M Hol
Journal:  Fluids Barriers CNS       Date:  2022-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.